A carregar...
PD-1 Inhibition Minimally Affects Cisplatin-Induced Toxicities in a Murine Model
Immune checkpoint inhibition used in combination with standard cisplatin-based chemotherapy regimens is currently under evaluation in clinical trials for head and neck squamous cell carcinoma (HNSCC). The impact of anti–PD-1 therapy on cisplatin-induced ototoxicity and nephrotoxicity has not been es...
Na minha lista:
| Publicado no: | Otolaryngol Head Neck Surg |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6134261/ https://ncbi.nlm.nih.gov/pubmed/29609517 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0194599818767621 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|